Literature DB >> 17949964

The sound of silence: modulating anergy in T lymphocytes.

Samuel D Saibil1, Elissa K Deenick, Pamela S Ohashi.   

Abstract

Understanding the intercellular and intracellular mechanisms that maintain anergy and prevent the induction of full effector function is one avenue that may allow us to manipulate immune responses. Recent studies of T cell receptor (TCR)-proximal signaling events in different models of T cell unresponsiveness have suggested that biochemically distinct forms of anergy may exist in vivo. T cell responsiveness can be altered through the control of the intracellular pool of key second messengers, such as diacylglycerol (DAG) or the lipid modification of signaling molecules, such as the Linker for activated T cells (LAT). Studies on the molecule programmed death-1 (PD-1) and its ligands have revealed that tissue-resident signals are essential in the maintenance of T cell unresponsiveness. Thus, the emerging view is that T cell anergy is a dynamic state whose establishment and maintenance can be influenced by numerous different signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949964     DOI: 10.1016/j.coi.2007.08.005

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  13 in total

Review 1.  Cbl-b in T-cell activation.

Authors:  Magdalena Paolino; Josef M Penninger
Journal:  Semin Immunopathol       Date:  2010-02-21       Impact factor: 9.623

2.  Pivotal Advance: Nonfunctional lung effectors exhibit decreased calcium mobilization associated with reduced expression of ORAI1.

Authors:  Subhashini Arimilli; Sharad K Sharma; Rama Yammani; Sean D Reid; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Leukoc Biol       Date:  2010-01-26       Impact factor: 4.962

Review 3.  The yin and yang of protein kinase C-theta (PKCθ): a novel drug target for selective immunosuppression.

Authors:  Elizabeth Yan Zhang; Kok-Fai Kong; Amnon Altman
Journal:  Adv Pharmacol       Date:  2013

4.  Imbalance of immunological synapse-kinapse states reflects tumor escape to immunity in glioblastoma.

Authors:  Laura R Díaz; Elena Saavedra-López; Leire Romarate; Izaskun Mitxitorena; Paola V Casanova; George P Cribaro; José M Gallego; Ana Pérez-Vallés; Jerónimo Forteza-Vila; Clara Alfaro-Cervello; José M García-Verdugo; Carlos Barcia; Carlos Barcia
Journal:  JCI Insight       Date:  2018-09-20

5.  Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2-mediated reversal of T-cell tolerance.

Authors:  Beixue Gao; Qingfei Kong; Kyeorda Kemp; Yuan-Si Zhao; Deyu Fang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-04       Impact factor: 11.205

6.  Autoimmunity in Coxsackievirus B3 induced myocarditis: role of estrogen in suppressing autoimmunity.

Authors: 
Journal:  Future Virol       Date:  2010-05-01       Impact factor: 1.831

7.  Immune regulation of cancer.

Authors:  Mary L Disis
Journal:  J Clin Oncol       Date:  2010-06-01       Impact factor: 44.544

8.  PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells.

Authors:  Vrajesh V Parekh; Saif Lalani; Sungjune Kim; Ramesh Halder; Miyuki Azuma; Hideo Yagita; Vipin Kumar; Lan Wu; Luc Van Kaer
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

9.  Fatigue-related gene networks identified in CD(14)+ cells isolated from HIV-infected patients: part I: research findings.

Authors:  Joachim G Voss; Adrian Dobra; Caryn Morse; Joseph A Kovacs; Robert L Danner; Peter J Munson; Carolea Logan; Zoila Rangel; Joseph W Adelsberger; Mary McLaughlin; Larry D Adams; Raghavan Raju; Marinos C Dalakas
Journal:  Biol Res Nurs       Date:  2013-01-16       Impact factor: 2.522

10.  Restricted autoantigen recognition associated with deletional and adaptive regulatory mechanisms.

Authors:  John A Gebe; Betty B Yue; Kelly A Unrath; Ben A Falk; Gerald T Nepom
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.